About us

Sci-Rec are a dedicated life science search and selection consultancy who thrive on the exciting intersection of science, talent, and innovation. With a deep understanding of the ever-evolving landscape across IVD, biotechnology and pharmaceuticals, we are committed to making meaningful connections that drive progress in these critical industries. We work globally and couldn't be further away from a typical transactional recruitment company; we take pride in building long lasting relationships and operate on a true partnership model with both clients and candidates. If you would like to learn more about our client or candidate services, don't hesitate to reach out to info@sci-rec.com.

Website
www.sci-rec.com
Industry
Staffing and Recruiting
Company size
1 employee
Headquarters
Leeds
Type
Public Company
Specialties
Recruitment, Consultancy, Staffing, IVD, Molecular Diagnostics, CDMO, Pharmaceuticals, Life Science, Biotechnology, Talent Strategy, Genomics, Proteomics, Drug Development, CRO, CMO, and Market Insights

Locations

Employees at Sci-Rec

Updates

  • View organization page for Sci-Rec, graphic

    3,508 followers

    📣 The Sci-Rec team has been relatively quiet lately, but it's all been for great reason! 📣 After 6 months of dedication to supporting our clients in the life science space, we're proud to unveil our fresh new look and feel! This reflects our evolution as a company, commitment to innovation, and serving our customers better than ever before, making sure our connections understand our essence and what drives us. 🤝 With a combined 20 years of recruitment experience, we're committed to "Navigating The Path To Discovery" and we're thrilled to share our latest endeavour with you. 🎥 Let us know your thoughts in the comments and share with your networks! Also, make sure to follow our page for more industry news and vacancies in the IVD and CDMO space! 🗞️ #scirec #CDMO #IVD

  • View organization page for Sci-Rec, graphic

    3,508 followers

    🚀 𝗪𝗼𝘄, what an 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 month it's been for the Sci-Rec team! 🚀 We’ve wrapped up 𝟲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗽𝗹𝗮𝗰𝗲𝗺𝗲𝗻𝘁𝘀 and secured 𝟳 𝗻𝗲𝘄 𝗿𝗲𝘁𝗮𝗶𝗻𝗲𝗿𝘀, with a whole week left in July to achieve even more! As summer approaches, we're not slowing down. We're full steam ahead, actively filling roles across the 𝗖𝗗𝗠𝗢, 𝗜𝗩𝗗, and 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 sectors. Curious about the opportunities? Reach out to Paul Atkinson, Harriet Wheat, or Adam Hargreaves for more information! 🌟 #Hiring #BioPharma #LifeScience #CDMO #IVD #Diagnostics

    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Sci-Rec, graphic

    3,508 followers

    Check out this article written by our CDMO expert Harriet Wheat. It dives into market insights, recent trends since COVID-19 and what this means for the CDMO industry. Don't forget to connect with her if you are looking for a new position in the CDMO industry! 📩 harriet.wheat@sci-rec.com #CDMO #Pharma #Biotech

    View profile for Harriet Wheat, graphic

    Director at Sci-Rec | Passionate Global CDMO Recruitment Executive! 🔬🧪

    𝗪𝗶𝗹𝗹 𝘁𝗵𝗲 𝗖𝗗𝗠𝗢 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗿𝗲𝗰𝗼𝘃𝗲𝗿 𝗳𝗿𝗼𝗺 𝗶𝘁𝘀 𝘀𝗹𝘂𝗺𝗽? 🤔 Check out an article I’ve been working on, which provides insights into market trends over the next few years, the effects of the COVID-19 boom, reasons for anticipated growth, and the impact on recruitment. Any support would be appreciated LinkedIn friends! 🤓 👏 Please comment with your thoughts and share with your network 👇 #CDMO #COVID19 #MarketTrends

    Will the CDMO Industry Pick Back Up After the COVID-19 Boom?

    Will the CDMO Industry Pick Back Up After the COVID-19 Boom?

    Harriet Wheat on LinkedIn

  • View organization page for Sci-Rec, graphic

    3,508 followers

    Sci-Rec are looking for a 𝗖𝗵𝗶𝗲𝗳 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 in North America to join a small molecule CDMO. 𝗠𝘂𝘀𝘁 𝗵𝗮𝘃𝗲 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴, 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗮𝗻𝗱 𝘀𝘂𝗽𝗽𝗹𝘆 𝗰𝗵𝗮𝗶𝗻 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗮𝘀 𝘄𝗲𝗹𝗹 𝗮𝘀 𝗺𝗮𝗻𝗮𝗴𝗲𝗱 𝘁𝗲𝗮𝗺𝘀 𝗶𝗻 𝗮 𝗱𝘆𝗻𝗮𝗺𝗶𝗰 𝘄𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲. If you are a VP looking for the next step up or a COO looking for a challenge with a smaller dynamic company, then check out the job add and reach out to Harriet Wheat if interested in discussing. #CDMO #COO #operations

  • View organization page for Sci-Rec, graphic

    3,508 followers

    ECCMID is just two months away now and its great to announce that we will be participating. ☀ This years event is the 34th edition and it will be held in #Barcelona. It is hard to argue against this been one of the better venues to host! Adam Hargreaves & Paul Atkinson will be attending from our team so feel free to message them to schedule a meeting. Between them, they have over 15 years experience recruiting in the Diagnostics space! #infectiousdisease #moleculardiagnostics

    • No alternative text description for this image
  • View organization page for Sci-Rec, graphic

    3,508 followers

    It has been a very busy few weeks for the team who are working across three different time zones with clients on new business. Role roundup 👇 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: - Principal Scientist - POC MDx - East Coast - Director Computational Biology - POC MDx - East Coast 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐬𝐭𝐫𝐮𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: - Sales Development Rep - Electron Microscopy - West Coast - Product Manager - Spectroscopy - East Coast 𝐂𝐃𝐌𝐎: - Vice President of Business Development - US - Small Molecules. - Business Development Director - US - Small Molecules/Oligos. - Head of Business Development - US - Small Molecules. - Business Development Manager - US, West Coast - Custom Synthesis. - Global Alliance Managers - Europe & US - Biologics. - Business Development Director - US, East & West Coast - Biologics. 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞: - Principal Systems Engineer - US, East Coast - Electromechanical Device 𝐁𝐨𝐚𝐫𝐝 𝐀𝐝𝐯𝐢𝐬𝐨𝐫: - Board Advisors - US/APAC - Corporate Development background. If interested then please reach out to Paul Atkinson, Harriet Wheat or Adam Hargreaves to learn more! 🔥 Q1 is heating up! #lifesciencejobs #hiring #diagnostics #CDMO

    • No alternative text description for this image
  • View organization page for Sci-Rec, graphic

    3,508 followers

    Saudi Arabia have launched a National strategy in an effort to become an International biotech hub by 2040 🌐🔬! 📈 Focused on vaccines, local bio-manufacturing, genomics, and plant optimization, this initiative aims to position them as a biotech leader in the MENA region initially by 2030. Positive news for our market which will drive economic growth, job creation and hopefully a healthy future 🇸🇦💡 💭 Thoughts?! #lifescience #biotechnology #innovation

    Saudi Arabia launches plan to become biotech hub by 2040

    Saudi Arabia launches plan to become biotech hub by 2040

    fiercebiotech.com

  • View organization page for Sci-Rec, graphic

    3,508 followers

    💡 A great overview from Harriet Wheat on the CDMO market and what she expects from 2024. If you’re looking for a new role in the CDMO industry then connect with her on LinkedIn for a short discussion. Don’t forget to follow Sci-Rec for more industry’s news across the Life Science Arena. #hiring #CDMO #lifescience #biopharma

    View profile for Harriet Wheat, graphic

    Director at Sci-Rec | Passionate Global CDMO Recruitment Executive! 🔬🧪

    2024 CDMO forecast 💭 2 years post pandemic and the CDMO industry has seen a collection of highs and lows, from expansions and investment to lay offs and closing of facility’s. 💰 However, it still remains one of the top biopharma fields; in terms of revenue and exciting science. 👩🏼🔬 In fact…. the CDMO market is poised to outpace overall pharma growth through 2028! So what should they be doing in 2024 to keep the market growing? 1. Embracing advanced therapeutics 2. Building trust with partners 3. Nudging regulators on novel production approaches. Unsurprisingly, oncology represents the fastest-growing CDMO market and injectables represent the largest looming revenue opportunity for CDMOs, followed by oral medications. 💊 But, companies are still facing funding struggles… There's a huge emphasis on milestones, which drugmakers typically have to pass to unlock more funding and continue workflow. Did you know??? Enlisting a CDMO earlier in the development lifecycle can help biopharmas secure funding. 💡 Due to rise in costs in 2020/2021, companies resorted to manufacturing the drugs themselves and building expensive to run facilities. As a result, a lot of companies are selling these facilities or spinning off into their own separate CDMO. Likely a big contributor to the CDMO market outgrowing Pharma. Overall, the biggest potential for CDMOs in 2024 would be to push their projects into the commercial stage. But you course this is easier said than done. 🧐 Ultimately, CDMOs and pharmas of all sizes need consistent regulatory guidance to embrace new manufacturing technologies. So, this year is all about regulatory advice, maintaining relationships, staying on top of cutting edge technology and getting drugs to commercial. Have I missed anything important for this years forecast? 📈 #2024 #cdmomarket #cdmo #pharma #biotech

    • No alternative text description for this image

Similar pages